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Background: Acute respiratory distress syndrome (ARDS) can result in a life-threatening form of respiratory
failure, and established, effective pharmacotherapies are therefore urgently required. Quercetin is one of the
most common flavonoids found in fruits and vegetables, and has potent anti-inflammatory and anti-oxidant
activities. Quercetin has been demonstrated to exhibit cytoprotective effects through the induction of heme
oxygenase (HO)-1. Here, we investigated whether the intratracheal administration of quercetin could suppress
lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice as well as the involvement of HO-1 in quercetin ? s
suppressive effects.
Methods: Mouse model of ALI were established by challenging intratracheally LPS. The wet lung-to-body weight ratio,
matrix metalloproteinase (MMP)-9 activities, and pro-inflammatory cytokine productions, including tumor necrosis
factor (TNF)-α, interleukin (IL)-1β, and IL-6 in bronchoalveolar lavage fluid (BALF) were examined in ALI mice with
or without quercetin pretreatment. We also examined the effects of quercetin on LPS stimulation in the mouse
alveolar macrophage cell line, AMJ2-C11 cells.
Results: Intratracheal administration of quercetin decreased the wet lung-to-body weight ratio. Moreover, quercetin
decreased MMP-9 activity and the production of pro-inflammatory cytokines in BALF cells activated by LPS in advance.
We determined the expression of quercetin-induced HO-1 in mouse lung, e.g., alveolar macrophages (AMs), alveolar
and bronchial epithelial cells. When AMJ2-C11 cells were cultured with quercetin, a marked suppression of LPS-induced
pro-inflammatory cytokine production was observed. The cytoprotective effects were attenuated by the addition of the
HO-1 inhibitor SnPP. These results indicated that quercetin suppressed LPS-induced lung inflammation, and that an
HO-1-dependent pathway mediated these cytoprotective effects.
Conclusions: Our findings indicated that quercetin suppressed LPS-induced lung inflammation, and that an
HO-1-dependent pathway mediated these cytoprotective effects. Intratracheal administration of quercetin will lead
to new supportive strategies for cytoprotection in these serious lung conditions.
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Acute respiratory distress syndrome (ARDS) continues to
be major causes of mortality in the intensive care units, even
though mechanical ventilation with low tidal volume [1],
early neuromuscular blockade [2], and prone positioning [3]
have been shown to reduce mortality from ARDS. No
pharmacotherapy has proven effective in decreasing mortal-
ity in adult patients with ARDS [4]. The pathophysiology of
ARDS involves inflammation with diffuse alveolar damage,
formation of hyaline membranes, increased capillary perme-
ability, interstitial edema, and influx of circulating inflamma-
tory cells [5]. Although neutrophil influx and activation
within the lung are important factors in the pathogenesis of
ARDS, alveolar macrophages (AMs) and alveolar and bron-
chial epithelial cells are also involved in the disease process
[5,6]. In particular, increasing evidence demonstrates that
AMs contribute to the modulation of inflammatory re-
sponses and the resultant lung injury [7,8]. Pro-inflammatory
cytokines, including tumor necrosis factor (TNF)-α,
interleukin (IL)-1β, and IL-6, secreted by AMs stimulate
neutrophils, and these activated neutrophils release
oxidants, proteases, leukotrienes, and platelet activating
factors, resulting in the development of ARDS [5].
Lipopolysaccharide (LPS), a component of the cell wall
of Gram-negative bacteria, can induce inflammatory re-
sponses and disturb immune system function [9]. Intratra-
cheal administration of LPS has gained wide acceptance as
a clinically relevant model of ARDS in mice [10].
Quercetin is one of the most abundant dietary flavo-
noids and is found in a broad range of fruits, vegetables,
and beverages. Quercetin has been demonstrated to
have potent anti-inflammatory and anti-oxidant activ-
ities [11,12]. We reported that quercetin exhibited
cytoprotective effects through the induction of heme
oxygenase (HO)-1 [11,13,14]. HO-1 is a stress-inducible
protein and catalyzes the rate-limiting step in the degrad-
ation of heme to biliverdin, carbon monoxide (CO),
and ferrous iron [15].
ARDS often develops in intubated patients. During in-
tubation management, the antioxidants supplied from a
regular diet cannot be taken in. Therefore, we first fo-
cused on the prophylactic effects of quercetin to prevent
the development of ARDS in high-risk patients. To
qualify as a prophylactic treatment, it must be harmless,
relatively inexpensive, and easily and widely applicable. It
is thought that quercetin fulfills these conditions. More-
over, we considered that local administration to the lung
could more effectively reveal the effects of quercetin,
which is not easily absorbed, in the lung.
In this study, we investigated whether the intratracheal
administration of quercetin could suppress LPS-induced
acute lung injury (ALI).
We also investigated the involvement of HO-1 in the
suppressive effects of quercetin.Materials and methods
Reagents
LPS from Klebsiella pneumoniae LEN-1 (O3:K1−) was
kindly donated by Prof. T. Hasegawa (Aichi Medical
University School of Medicine, Aichi, Japan). Quercetin
was obtained from Sigma (St. Louis, MO). Tin protopor-
phyrin IX (SnPP) was obtained from Frontier Scientific
(Carnforth, UK).
Cell culture
The mouse AM cell line, AMJ2-C11, and the mouse al-
veolar epithelial cell line, LA-4, were purchased from the
American Type Culture Collection (Manassas, VA). The
cdk4/hTERT-immortalized normal human bronchial epi-
thelial cell line, HBEC4 [16] was obtained from the Hamon
Center Collection (University of Texas Southwestern
Medical Center, Dallas, TX). AMJ2-C11 and LA-4 cells
were cultured in Dulbecco ? s Modified Eagle ? s Medium
supplemented with 100 U/ml penicillin, 0.1 U/ml strepto-
mycin, 2.5x10−4 U/ml amphotericin B, 1 mM sodium pyru-
vate, Minimum Essential Medium (MEM) non-essential
amino acids, and 10% Fetal bovine serum (FBS). HBEC4
cells were cultured in keratinocyte serum-free medium
(Life Technologies, Gaithersburg, MD) supplemented with
50 ng/ml bovine pituitary extract and 5 ng/ml epidermal
growth factor. Cells were grown under standard conditions
in a humidified incubator at 37?C and 5% CO 2.
Animals
Wild-type BALB/c mice were purchased from SLC
(Shizuoka, Japan). 8- to 12-week-old mice (weight: 18 ?
25 g) matched for age and weight were used for the
studies. Animals were maintained in a temperature
(22-24?C), humidity (55 ? 5%), and light (12 hours light ?
dark cycle; lights on at 8:00) regulated room with access
to food and water ad libitum. All procedures were per-
formed in accordance with the Guidelines for Animal
Experimentation of Nagoya University.
Mouse model of ALI
Mice were randomly divided into 4 groups (each group:
n = 3 ~ 5): control (Phosphate buffered saline (PBS))-
treated, quercetin-treated, LPS-treated, and quercetin +
LPS-treated. We made a small incision on the neck of
mouse ? s skin and exposed a trachea under sodium
pentobarbital anesthesia. Then the mice were challenged
intratracheally with either 50 μl PBS alone or 50 μl PBS of
1.25 μg LPS by stabbing the trachea with a microsyringe
with a 22-gauge needle. In some experiments, mice were
administered 50 μl of 0.1% propylene glycol (vehicle) or
10 μM quercetin in 0.1% propylene glycol intratracheally
6 hours before LPS challenge. The bronchoalveolar lavage
fluid (BALF) and lungs were collected 24 hours after LPS
administration in separate experiments. The severity of
Figure 1 The effects of quercetin on LPS-induced ALI. Mice were
challenged with LPS or PBS 6 hours after intratracheal administration
of quercetin or vehicle. After 24 hours, the lung tissue and BALF were
collected. (A) The wet lung-to-body weight ratio. (B) Histological images
of lung tissues. (b1) vehicle-PBS; (b2) quercetin-PBS; (b3) vehicle-LPS; (b4)
quercetin-LPS. Original magnification: ?100. Each photograph represents
three independent experiments. (C) Inflammatory cell numbers in BALF.
Total, total cell count; Neut, neutrophils; Mono/Macro, monocytes/
macrophages; Lym, lymphocytes. Vertically striped bars, vehicle-PBS;
horizontally striped bars, quercetin-PBS, open bars; vehicle-LPS, filled
bars; quercetin-LPS. Results are shown as the mean ? SD (* p < 0.05)
of three independent experiments.
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pathological changes in lung tissues, and cellular profiles
in BALF.
Collection of BALF
BALF were collected as previously described [7]. Briefly,
mice were exsanguinated by aortic perforation under
pentobarbital anesthetization. The trachea was cannulated,
and the lungs were lavaged six times with PBS (0.5 ml each
time). Collected BALF were centrifuged at 1,200 rpm for
3 minutes, and the pelleted cells were then re-suspended
in RPMI-1640 medium supplemented with 100 U/ml peni-
cillin, 0.1 U/ml streptomycin, 2.5x10−4 U/ml amphotericin
B, 1 mM sodium pyruvate, MEM non-essential amino
acids, 50 μM 2-mercaptoethanol, and 10% FBS.
Leukocyte counts in BALF
The number of leukocytes was enumerated with a
hemocytometer. For differential counts, smears of BALF
cells from each mouse were prepared with centrifugation
using Cytofuge2 (StatSpin, Norwood, MA) at 1,000 revo-
lution per minute for 2 minutes and then stained with
May-Gr?nwald and Giemsa solutions.
Wet lung-to-body weight ratio
The lungs were removed from the thoracic cavity and
cleared of extraneous tissue. Each lung was weighed, and
the wet lung-to-body weight ratio was then calculated to
assess lung inflammation.
Histological study
For histological examination, paraffin sections (6 μm thick)
were stained with hematoxylin and eosin (H&E). For
immunohistochemical examination, 3-μm sections were
treated with 0.3% hydrogen peroxide, and then treated
with 10% goat serum (Nichirei Biosciences, Tokyo, Japan)
prior to incubating with a primary antibody against HO-1
(Enzo, Lausen, Switzerland) followed by the secondary
antibody, Simple Stain Mouse MAX-PO (R) (Nichirei
Biosciences). The slides were then visualized with DAB
chromogen (Vector Laboratories, Burlingame, CA). The
sections were counterstained with hematoxylin.
Cell activation
As for HO-1 mRNA and protein expression in AMJ2-
C11, LA-4, and HBEC4 cells, cells were cultured with
various concentrations (0, 5, 10, 20 μM) of quercetin for
4 or 8 hours, respectively. As for the cytokine expression
and production in AMJ2-C11 cells or BALF cells, cells
were cultured with quercetin (AMJ-2C11 cells; 20 μM,
BALF cells; 10 μM) for 1 hour and then stimulated with
LPS (5 μg/ml) for 2 hours or 18 hours, respectively. In
some experiments, AMJ-2C11 cells were treated with
SnPP (20 μM) for 30 minutes before quercetin treatment.As for the MMPs activity and cytokine production in acti-
vated BALF cells in advance, BALF were collected 24 hours
after an intratracheal LPS challenge and cultured with
quercetin or vehicle for 1 hour. After the medium was
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cetin for another 18 hours and the supernatant was
collected.
Western blotting
Western blotting was performed as described previously
[14]. For analysis of HO-1 in vivo, lungs were collected
6 hours after intratracheal administration of vehicle or
quercetin. For analysis of HO-1 in vitro, AMJ2-C11, LA-4,
and HBEC4 cells were cultured with various concentra-
tions (0, 5, 10, 20 μM) of quercetin for 8 hours.
Reverse transcription (RT) - polymerase chain reaction
(PCR), quantitative real-time PCR
Total ribonucleic acid (RNA) was isolated using ISO-
GEN II (Nippon Gene, Toyama, Japan) and reverse-
transcribed to cDNA using PrimeScript RT MasterMix
(Takara Bio, Shiga, Japan). Quantitative real-time PCR
was performed on a Thermal Cycler Dice Real Time
System II (TaKaRa Bio). Primers and probes for Hmox1,
Tnfa, Il1b, Il6, Gapdh, HMOX1, and GAPDH were ob-
tained from Nippon EGT (Toyama, Japan). Transcripts
of Gapdh or GAPDH, as a house-keeping gene, were
quantified as endogenous reference RNA to normalize
each sample. Relative quantities of expression were esti-
mated by the standard curve method. The results wereFigure 2 The effects of intratracheal administration of quercetin on H
intratracheal administration of quercetin or vehicle. (A) Determination of HO
(*p < 0.05) of three independent experiments. (B) Determination of HO-1
arrows, alveolar epithelial cells; open arrows, bronchial epithelial cells. Or
independent experiments.normalized as relative expression, in which the average
value of Hmox1, Tnfa, Il1b, Il6, or HMOX1 was divided
by the average value of Gapdh or GAPDH. The ratio
was calculated by dividing the normalized values of stim-
ulated cells by the values in control cells.
Enzyme-linked immunosorbent assay (ELISA)
The cytokine production of TNF-α, IL-1β, and IL-6 in
cell culture supernatants was quantified using a murine
ELISA development kit (PEPROTECH, Rocky Hill, NJ)
according to the manufacturer ? s recommendations.
Gelatin zymography
Gelatin zymography to determine matrix metalloproteinase
(MMPs) activity was performed as previously described
with some modifications [7]. The molecular weights of the
gelatinolytic bands were estimated using Precision Plus
Protein marker (BIO-RAD, Carlsbad, CA). The intensities
of MMP-9 bands were estimated using Scion Image (Scion,
Fredrick, MD).
Statistical analysis
Statistical comparisons among the groups were assessed
by one-way analysis of variance (ANOVA). When F ra-
tios were significant (p < 0.05), Tukey-Kramer ? s post-hoc
test (between group comparison) were performed, andO-1 expression in mouse lung. Mice were sacrificed 6 hours after
-1 expression by western blotting. Results are shown as the mean ? SD
expression by immunohistrochemistry. Arrowheads, AMs; black
iginal magnification: ?200. Each image is representative of three
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analysis was performed with StatView (Abacus Concept
Inc., Gloucestershire, UK).
Results
Lung protective effects of quercetin on LPS-induced ALI
in mice
We examined the effects of quercetin on LPS-induced
ALI in mice. Mice were intratracheally challenged with
LPS in the absence and presence of quercetin pre-
treatment. The wet lung-to-body weight ratio in LPS-
challenged mice was significantly increased compared
to control mice. The wet lung-to-body ratio was signifi-
cantly decreased by quercetin pretreatment in mice chal-
lenged with LPS (Figure 1A). Lung histological sections
of LPS-challenged mice showed alveolar wall thickening
caused by edema, and marked and diffuse interstitial in-
filtration with neutrophils and monocytes/macrophages
(Figure 1B, panel b3). Numbers of total cells and neutro-
phils in the BALF were increased in LPS-challenged mice





























































Figure 3 The effects of quercetin on HO-1 expression in AMJ2-C11, LA
with various concentrations (0, 5, 10, 20 μM) of quercetin for 4 hours to de
(A), and for 8 hours to detect HO-1 protein expression determined by wes
three independent experiments. Asterisks, significantly different from the dawall thickening and interstitial infiltration (Figure 1B,
panel b4), and the number of total cells and neutrophils
showed a decreasing tendency (Figure 1C); however, due
to inter-animal variability, this was not statistically sig-
nificant. These results indicated that quercetin pretreat-
ment attenuated LPS-induced ALI in mice.
HO-1 expression induced by intratracheal administration
of quercetin in mouse lung
We previously reported that quercetin exhibited cyto-
protective effects via HO-1 induction [11,13]. Therefore,
we next examined the expression of HO-1 in mouse
lung 6 hours after intratracheal administration of quer-
cetin using western blotting and immunohistochemistry.
Figure 2A shows that the expression of HO-1 was sig-
nificantly increased in lungs after administration of quer-
cetin. In addition, increased expression of HO-1 was
observed in AMs, alveolar and bronchial epithelial cells
(Figure 2B). These results indicated that intratracheal ad-
ministration of quercetin induced HO-1 in the mouse lung,
especially in AMs, alveolar and bronchial epithelial cells.1         1.3          1.9           3.0   
1         2.6           3.4         4.4   
β-actin
HO-1
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Relative protein levels
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Relative protein levels
-4, and HBEC4 cells. AMJ2-C11, LA-4, and HBEC4 cells were cultured
tect HO-1 mRNA expression determined by quantitative real-time PCR
tern blotting (B), respectively. Results are shown as the mean ? SD of
te at concentration zero of quercetin treated (p < 0.05).
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and bronchial epithelial cells
We examined the induction of HO-1 mRNA and protein
expression in AMs, alveolar and bronchial epithelial cells,
using the mouse AM cell line AMJ2-C11, the mouse al-
veolar epithelial cell line LA-4, and the human bronchial
epithelial cell line HBEC4, respectively. HO-1 expression,
both at the mRNA level and at the protein level, was dose-
dependently induced by quercetin in AMJ2-C11 cells. In
AMJ2-C11 cells, at the highest quercetin concentration,
the expression was increased up to 3.5-fold for mRNA
and 2.7-fold for protein compared to control (Figure 3).
Increased HO-1 expression by quercetin was also ob-
served in LA-4 and HBEC4 cells. Consistent with results
shown in Figure 2, these results suggested that HO-1Figure 4 The involvement of HO-1 in the suppressive effects of querc
AMJ2-C11 cells were cultured with quercetin (20 μM) for 1 hour after treatm
(5 μg/ml) for 2 hours to detect the mRNA expression of TNF-α, IL-1β, and I
detect the production of TNF-α, IL-1β, and IL-6 determined by ELISA (B), re
independent experiments.expression was significantly upregulated in lung tissue cells
by quercetin.
Suppressive effects of quercetin-induced HO-1 on
LPS-induced pro-inflammatory cytokine production in
AMJ2-C11 cells
From the results so far, we hypothesize that the induc-
tion of HO-1 could be associated with the biological po-
tency of quercetin as an inhibitor of pro-inflammatory
cytokines released by activated AMs and epithelial cells.
AMs in the lung are known to be a critical modulator of
inflammatory responses through the production of vari-
ous pro-inflammatory cytokines [5,7]. To investigate the
role of HO-1 on quercetin-induced inhibition of AMs
activated by LPS, AMJ2-C11 cells were exposed to SnPP,etin on LPS-induced pro-inflammatory cytokine production.
ent of SnPP (20 μM) for 30 minutes, and then stimulated with LPS
L-6 determined by quantitative real-time PCR (A), and for 18 hours to
spectively. Results are shown as the mean ? SD (* p < 0.05) of three
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stimulated with LPS. As shown in Figure 4, a marked
suppression in the mRNA expression and production of
TNF-α, IL-1β, and IL-6 induced by LPS was observed in
quercetin-cultured AMJ2-C11 cells. The cells exposed to
SnPP inhibited the quercetin-induced suppression of
TNF-α, IL-1β, and IL-6 production. These results sug-
gested that HO-1 was involved in the suppressive effects
of quercetin on the production of LPS-induced pro-
inflammatory cytokines in AMJ2-C11 cells.
Suppressive effects of quercetin on LPS-induced
pro-inflammatory cytokine production in BALF cells
To further determine the suppressive effects of quercetin
ex vivo, BALF cells were isolated from mice and stimu-
lated with LPS after treatment with quercetin. Consist-
ent with the results shown in Figure 4, the increase in
mRNA expression and production of TNF-α, IL-1β, and
IL-6 in BALF cells after stimulation with LPS was signifi-
cantly suppressed by quercetin pretreatment (Figure 5).Figure 5 The effects of quercetin on LPS-induced pro-inflammatory c
quercetin (10 μM) or vehicle for 1 hour were stimulated with LPS (5 μg
IL-6 determined by quantitative real-time PCR (A), and for 18 hours to d
(B), respectively. Results are shown as the mean ? SD (* p < 0.05) of threeThese results suggested that quercetin had cytoprotec-
tive effects ex vivo against the activation of AMs induced
by LPS.
Suppression of MMP-9 activity and pro-inflammatory
cytokine production in LPS- induced ALI by quercetin
To examine the effects of quercetin on BALF cells acti-
vated by LPS in advance, BALF were collected 24 hours
after an intratracheal challenge with LPS and then treated
with quercetin. As shown in Figure 6A, quercetin de-
creased both latent and active MMP-9 activities in BALF
cells in LPS-treated mice, and the degree of suppression
tended to be larger in active MMP-9 activities than in la-
tent ones, but not statistically significant. We next exam-
ined the production of TNF-α, IL-1β, and IL-6 in the
supernatant of BALF cells in LPS-treated mice. Consistent
with the results in Figure 5, quercetin significantly reduced
TNF-α, IL-1β, and IL-6 levels (Figure 6B). These results
indicated that quercetin reduced the inflammatory re-
sponses in cells activated by LPS in advance in vivo.ytokine production in BALF cells ex vivo. BALF cells cultured with
/ml) 2 hours to detect the mRNA expression of TNF-α, IL-1β, and
etect the production of TNF-α, IL-1β, and IL-6 determined by ELISA
independent experiments.
Figure 6 The effects of quercetin on MMP-9 activity and pro-inflammatory cytokine production in LPS-induced ALI. BALF were collected
24 hours after an intratracheal LPS challenge and cultured with quercetin or vehicle for 1 hour. After the medium was changed, BALF cells were
cultured with vehicle or quercetin for another 18 hours and the supernatant was collected. (A) MMP-9 activity in the supernatant was determined
by zymography. Latent (92 kDa) and active (88 kDa) MMP-9 and latent (72 kDa) MMP-2 activities are observed as clear zones of lysis against a dark
background. MMP-9 activities were quantified by measuring the band intensities. (B) The production of TNF-α, IL-1β, and IL-6 in the supernatant
was determined by ELISA. Results are shown as the mean ? SD (* p < 0.05) of three independent experiments.
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In the current study, we first demonstrated that the
intratracheal administration of quercetin attenuated LPS-
induced ALI in mice and that quercetin suppressed LPS-
induced pro-inflammatory cytokine production via an
HO-1-dependent pathway. Furthermore, quercetin de-
creased the activity of MMP-9 and the production of
pro-inflammatory cytokines in BALF cells activated by
LPS in advance.
Intragastric administration of quercetin has been dem-
onstrated to show preventive effects in LPS-induced sep-
sis in mice [17]. Although the daily dietary intake of
quercetin has been estimated as 5? 40 mg/day in humans
[18], total quercetin derived from the diet was reported
to be in the nanomolar range (<100 nM) in plasma as aresult of its poor absorption and metabolism [19]. Fur-
thermore, daily supplementation with 1 g of quercetin
for 4 weeks increased plasma concentrations only up to
1.5 μM [20], which could not provide adequate amounts
of quercetin to produce anti-inflammatory and anti-
oxidant effects [19]. In consideration of these reports on
the low bioavailability and the inability of patients with
serious diseases, such as ARDS, to take quercetin orally,
we administered quercetin intratracheally to maintain
quercetin at high local concentrations.
We demonstrated that intratracheal prophylactic quer-
cetin treatment suppressed the LPS-induced increase in
the wet lung-to-body weight ratio. The wet lung-to-body
weight ratio, an index of pulmonary edema, is correlated
with the severity of lung injury, as previously reported
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ARDS, is associated with the malfunction of two lung
cellular barriers: epithelial and endothelial cells [22].
Quercetin has been shown to improve the barrier function
of both epithelial and endothelial cell [23,24]. Considering
our results and previous reports together, the improvement
of barrier function might be involved in the mechanism of
suppression by quercetin on LPS-induced inflammation.
Moreover, pro-inflammatory cytokines such as TNF-α,
IL-1β, and IL-6 were reported to be increased in pa-
tients with ARDS, and play an important role in the
initiation and propagation of the inflammatory cascade
in ARDS [5,25]. Suppression of pro-inflammatory cyto-
kine production by quercetin pretreatment may also
have contributed to the attenuation of LPS-induced ALI
in mice.
Lung protection as a consequence of HO-1 induction
has been demonstrated in a number of lung injury
models in vitro and in vivo [26]. HO-1 is an essential en-
zyme that catalyzes the degradation of heme to ferrous
iron, CO, and biliverdin, which is subsequently con-
verted to bilirubin [15]. The protective effects of HO-1
against inflammation are considered not only to de-
crease harmful heme, but also to produce the metabo-
lites CO and bilirubin, which have the cytoprotective
effects [27,28]. Importantly, quercetin induced the sig-
nificant upregulation of HO-1 expression [13,14]. In fact,
in this study quercetin induced HO-1 in AMs, alveolar
and bronchial epithelial cells in mouse lung. Our results
are consistent with previous reports that HO-1 expres-
sion was detected in AMs and epithelial cells in lungs
with LPS stimulation or oxidative stress [29,30]. Further-
more, we confirmed the induction of HO-1 expression
in these types of cells using cell lines. AMs and lung epi-
thelial cells may produce pro-inflammatory cytokines
locally in the lung in ARDS [5], so it makes sense that
HO-1, which has anti-inflammatory effects, is expressed
on these cells.
We investigated the activities of MMPs other than on
the secretion of cytokines. MMP-9 is mainly produced
by inflammatory cells, such as neutrophils and macro-
phages, and activation mechanisms of MMP-9 are in-
volved in other MMPs, such as MMP-3, and neutrophil
elastase [31,32]. The levels of MMP-9, which is a major
factor in neutrophil migration across basement mem-
branes [33], have been reported to be increased in pa-
tients with ARDS [34]. We observed that quercetin
decreased the activity of MMP-9, the inhibition of which
could mitigate the inflammatory response in lungs by
suppressing the production of MMP-3 and neutrophil
elastase [35,36]. In fact, mice lacking MMP-9 and the in-
hibition of MMP-9 have shown less lung injury [37,38].
Taken together, it is suggested that quercetin could
suppress LPS-induced inflammation and have beneficialeffects on lungs not only as a prophylactic treatment but
also a supportive therapeutic drug.
Conclusions
The present study demonstrated that the prophylactic
effects of quercetin exhibited on LPS-induced lung in-
flammation, and that the HO-1-dependent pathway me-
diated these protective effects. Our findings indicate that
intratracheal administration is a desirable method to ef-
fectively exert the cytoprotective effects of quercetin.
Intratracheal administration of quercetin will lead to new
supportive strategies for cytoprotection in serious condi-
tions in the lung.
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